$66.18
1.55% yesterday
Nasdaq, Nov 07, 10:00 pm CET
ISIN
US30063P1057
Symbol
EXAS

Exact Sciences Corporation Target price 2025 - Analyst rating & recommendation

Exact Sciences Corporation Classifications & Recommendation:

Buy
87%
Hold
13%

Exact Sciences Corporation Price Target

Target Price $69.47
Price $66.18
Potential
Number of Estimates 24
24 Analysts have issued a price target Exact Sciences Corporation 2026 . The average Exact Sciences Corporation target price is $69.47. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 30 analysts: 26 Analysts recommend Exact Sciences Corporation to buy, 4 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Exact Sciences Corporation stock has an average upside potential 2026 of . Most analysts recommend the Exact Sciences Corporation stock at Purchase.

Sales and Margin forecast 2025, 2026 to 2032

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Revenue Billion $ 2.76 3.22
10.36% 16.68%
EBITDA Margin -6.09% 14.51%
25.90% 338.08%
Net Margin -37.29% -3.79%
356.64% 89.84%

28 Analysts have issued a sales forecast Exact Sciences Corporation 2025 . The average Exact Sciences Corporation sales estimate is

$3.2b
Unlock
. This is
9.49% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$3.3b 13.27%
Unlock
, the lowest is
$3.1b 4.90%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 $2.8b 10.36%
2025
$3.2b 16.68%
Unlock
2026
$3.6b 12.36%
Unlock
2027
$4.0b 11.69%
Unlock
2028
$4.3b 6.53%
Unlock
2029
$4.5b 5.25%
Unlock
2030
$4.6b 1.19%
Unlock
2031
$4.8b 5.26%
Unlock
2032
$5.0b 4.23%
Unlock

27 Analysts have issued an Exact Sciences Corporation EBITDA forecast 2025. The average Exact Sciences Corporation EBITDA estimate is

$467m
Unlock
. This is
602.90% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$498m 650.06%
Unlock
, the lowest is
$334m 402.83%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 $-168m 18.22%
2025
$467m 377.83%
Unlock
2026
$646m 38.26%
Unlock
2027
$852m 31.86%
Unlock
2028
$1.0b 22.58%
Unlock
2029
$1.3b 21.46%
Unlock
2030
$1.4b 10.33%
Unlock
2031
$1.7b 20.01%
Unlock
2032
$1.8b 9.29%
Unlock

EBITDA Margin

2024 -6.09% 25.90%
2025
14.51% 338.08%
Unlock
2026
17.86% 23.09%
Unlock
2027
21.08% 18.03%
Unlock
2028
24.26% 15.09%
Unlock
2029
27.99% 15.38%
Unlock
2030
30.52% 9.04%
Unlock
2031
34.80% 14.02%
Unlock
2032
36.49% 4.86%
Unlock

27 Exact Sciences Corporation Analysts have issued a net profit forecast 2025. The average Exact Sciences Corporation net profit estimate is

$-122m
Unlock
. This is
87.86% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$-91.4m 90.91%
Unlock
, the lowest is
$-154m 84.69%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 $-1.0b 403.97%
2025
$-122m 88.13%
Unlock
2026
$80.0m 165.54%
Unlock
2027
$201m 150.87%
Unlock
2028
$394m 96.16%
Unlock
2029
$550m 39.70%
Unlock
2030
$843m 53.33%
Unlock
2031
$990m 17.39%
Unlock
2032
$1.1b 13.45%
Unlock

Net Margin

2024 -37.29% 356.64%
2025
-3.79% 89.84%
Unlock
2026
2.21% 158.31%
Unlock
2027
4.97% 124.89%
Unlock
2028
9.15% 84.10%
Unlock
2029
12.14% 32.68%
Unlock
2030
18.40% 51.57%
Unlock
2031
20.52% 11.52%
Unlock
2032
22.34% 8.87%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Earnings Per Share $ -5.59 -0.65
394.69% 88.37%
P/E negative
EV/Sales 4.36

27 Analysts have issued a Exact Sciences Corporation forecast for earnings per share. The average Exact Sciences Corporation EPS is

$-0.65
Unlock
. This is
87.78% higher
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
$-0.48 90.98%
Unlock
, the lowest is
$-0.81 84.77%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $-5.59 394.69%
2025
$-0.65 88.37%
Unlock
2026
$0.42 164.62%
Unlock
2027
$1.06 152.38%
Unlock
2028
$2.08 96.23%
Unlock
2029
$2.91 39.90%
Unlock
2030
$4.46 53.26%
Unlock
2031
$5.23 17.26%
Unlock
2032
$5.94 13.58%
Unlock

P/E ratio

Current -12.44 79.15%
2025
-102.58 724.61%
Unlock
2026
156.51 252.57%
Unlock
2027
62.39 60.14%
Unlock
2028
31.81 49.01%
Unlock
2029
22.77 28.42%
Unlock
2030
14.85 34.78%
Unlock
2031
12.65 14.81%
Unlock
2032
11.15 11.86%
Unlock

Based on analysts' sales estimates for 2025, the Exact Sciences Corporation stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 4.77 11.17%
2025
4.36 8.69%
Unlock
2026
3.88 11.00%
Unlock
2027
3.47 10.47%
Unlock
2028
3.26 6.13%
Unlock
2029
3.10 4.99%
Unlock
2030
3.06 1.18%
Unlock
2031
2.91 4.99%
Unlock
2032
2.79 4.06%
Unlock

P/S ratio

Current 4.27 10.96%
2025
3.90 8.67%
Unlock
2026
3.47 11.01%
Unlock
2027
3.10 10.47%
Unlock
2028
2.91 6.13%
Unlock
2029
2.77 4.99%
Unlock
2030
2.74 1.18%
Unlock
2031
2.60 4.99%
Unlock
2032
2.49 4.06%
Unlock

Current Exact Sciences Corporation Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
Wells Fargo
Locked
Locked
Locked Nov 05 2025
BTIG
Locked
Locked
Locked Nov 04 2025
TD Cowen
Locked
Locked
Locked Nov 04 2025
Stifel
Locked
Locked
Locked Nov 04 2025
Baird
Locked
Locked
Locked Nov 04 2025
Guggenheim
Locked
Locked
Locked Nov 04 2025
Barclays
Locked
Locked
Locked Nov 04 2025
Analyst Rating Date
Locked
Wells Fargo:
Locked
Locked
Nov 05 2025
Locked
BTIG:
Locked
Locked
Nov 04 2025
Locked
TD Cowen:
Locked
Locked
Nov 04 2025
Locked
Stifel:
Locked
Locked
Nov 04 2025
Locked
Baird:
Locked
Locked
Nov 04 2025
Locked
Guggenheim:
Locked
Locked
Nov 04 2025
Locked
Barclays:
Locked
Locked
Nov 04 2025

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today